Characterization of skin adverse events associated with cetuximab: real-world insights from the two global pharmacovigilance databases of FAERS and VigiAccess

BackgroundCetuximab, an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR), is widely used in metastatic colorectal cancer and other solid tumors. Cutaneous adverse events (AEs) are among its most frequent toxicities, but real-world evidence on their spectrum and risk pro...

詳細記述

書誌詳細

主要な著者:	Chenwen Li, Yifei Gao, Min Guang, Huajuan Wu, Yunfei Li, Yaqing Lu, Yan Wei, Xueli Li, Li Yang
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2026-02-01
シリーズ:	Frontiers in Oncology
主題:	cetuximab disproportionality analysis FAERS skin adverse events VigiAccess
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1768984/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!